Detecting high-grade cervical disease on ASC-H cytology: role of BD ProEx C and Digene Hybrid Capture II HPV DNA testing.

TitleDetecting high-grade cervical disease on ASC-H cytology: role of BD ProEx C and Digene Hybrid Capture II HPV DNA testing.
Publication TypeJournal Article
Year of Publication2008
AuthorsSiddiqui MT, Cohen C, Nassar A
JournalAm J Clin Pathol
Volume130
Issue5
Pagination765-70
Date Published2008 Nov
ISSN1943-7722
KeywordsAdult, Aged, Antigens, Neoplasm, Cell Cycle Proteins, Cervical Intraepithelial Neoplasia, DNA Topoisomerases, Type II, DNA, Viral, DNA-Binding Proteins, Female, Humans, Middle Aged, Minichromosome Maintenance Complex Component 2, Nuclear Proteins, Papillomaviridae, Papillomavirus Infections, Precancerous Conditions, Reagent Kits, Diagnostic, Sensitivity and Specificity, Tumor Virus Infections, Uterine Cervical Neoplasms
Abstract

The BD ProEx C stain (BD Diagnostics-Tripath, Burlington, NC) detects 2 molecular markers known to be overexpressed in cervical squamous cell carcinoma, minichromosome maintenance protein 2 and topoisomerase II. This study was conducted to evaluate this stain detecting high-grade cervical disease, and results were compared with high-risk HPV (hr-HPV) status and histologic biopsy diagnosis in Papanicolaou tests with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H) cytologic results. Cervical cytology specimens were collected in BD SurePath preservative (BD Diagnostics-Tripath), and 100 specimens with a diagnosis of ASC-H were included in the study. A second BD SurePath slide, prepared from the residual cellular material from these ASC-H cases, was immunostained using the BD ProEx C reagent. Nuclear staining of ASC-H cells was considered a positive result. The sensitivity for BD ProEx C for detecting cervical intraepithelial neoplasia 2 or worse was 98.8% and for hr-HPV was 71.1%, whereas specificity values were 82.4% and 64.7%, respectively. BD ProEx C has potential as a marker for detection of high-grade disease in patients with ASC-H cytologic results.

DOI10.1309/AJCPWW6V2KGXODUI
Alternate JournalAm J Clin Pathol
PubMed ID18854269
Related Faculty: 
Momin Siddiqui, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700